The lack of NLRP3 significantly reduced lung cancer metastasis and improved melanoma survival rate while promoting colorectal cancer metastasis and hepatocellular carcinoma progression (Hamarsheh and Zeiser, 2020). Here, NLRP3 is linked to lung cancer.